Structure-activity relationship on human serum paraoxonase (PON1) using substrate analogues and inhibitors

被引:16
作者
Bargota, RS
Akhtar, M
Biggadike, K
Gani, D
Allemann, RK
机构
[1] Univ Birmingham, Sch Chem Sci, Birmingham B15 2TT, W Midlands, England
[2] GlaxoSmithKline, Med Res Ctr, Stevenage SG1 2NY, Herts, England
关键词
D O I
10.1016/S0960-894X(03)00290-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Substrate analogues based on the parent compounds paraoxon and phenyl acetate were tested on human serum paraoxonase (PON1) to explore the active site of the enzyme. Replacement of the nitro group of paraoxon with an amine or hydrogen, as well as electronic changes to the parent compound, converted these analogues into inhibitors. Introduction of either electron-withdrawing or donating groups onto phenyl acetate resulted in reduction in their rate of hydrolysis by PON1. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1623 / 1626
页数:4
相关论文
共 36 条
[2]   The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns [J].
Antikainen, M ;
Murtomaki, S ;
Syvanne, M ;
Pahlman, R ;
Tahvanainen, E ;
Jauhiainen, M ;
Frick, MH ;
Ehnholm, C .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :883-885
[3]   ON SPECIFICITY OF ARYLESTERASES [J].
AUGUSTINSSON, KB ;
EKEDAHL, G .
ACTA CHEMICA SCANDINAVICA, 1962, 16 (01) :240-&
[4]   Does paraoxonase play a role in susceptibility to cardiovascular disease? [J].
Aviram, M .
MOLECULAR MEDICINE TODAY, 1999, 5 (09) :381-386
[5]   Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities [J].
Aviram, M ;
Hardak, E ;
Vaya, J ;
Mahmood, S ;
Milo, S ;
Hoffman, A ;
Billicke, S ;
Draganov, D ;
Rosenblat, M .
CIRCULATION, 2000, 101 (21) :2510-2517
[6]  
Aviram M, 2000, AM J CLIN NUTR, V71, P1062
[7]   Selective plasma hydrolysis of glucocorticoid γ-lactones and cyclic carbonates by the enzyme paraoxonase:: An ideal plasma inactivation mechanism [J].
Biggadike, K ;
Angell, RM ;
Burgess, CM ;
Farrell, RM ;
Hancock, AP ;
Harker, AJ ;
Irving, WR ;
Ioannou, C ;
Procopiou, PA ;
Shaw, RE ;
Solanke, YE ;
Singh, OMP ;
Snowden, MA ;
Stubbs, RJ ;
Walton, S ;
Weston, HE .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (01) :19-21
[8]  
Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335
[9]   The role of paraoxonase (PON1) is the detoxication of organophosphates and its human polymorphism [J].
Costa, LG ;
Li, WF ;
Richter, RJ ;
Shih, DM ;
Lusis, A ;
Furlong, CE .
CHEMICO-BIOLOGICAL INTERACTIONS, 1999, 119 :429-438
[10]   The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin [J].
Davies, HG ;
Richter, RJ ;
Keifer, M ;
Broomfield, CA ;
Sowalla, J ;
Furlong, CE .
NATURE GENETICS, 1996, 14 (03) :334-336